Benzinga | Jun 18, 2021 07:26AM EDT

Registration Statement Related To Cleveland BioLabs-Cytocom Merger Declared Effective By SEC

* Cleveland BioLabs Inc (NASDAQ:CBLI) says that the SEC registration statement regarding the previously announced merger with Cytocom Inc was declared effective by the SEC on June 10.

* The merger is expected to close in the Q3 of 2021, subject to approval by Cleveland BioLabs' stockholders.

* A special meeting of the Cleveland BioLabs stockholders related to the merger will be held virtually on July 6 at 10:00 a.m. E.T.

* After the deal's closure, the new combined company will be named Cytocom Inc, and its common stock will trade on NASDAQ under the symbol "CYTO."

* The deal was initially announced in October last year, and the registration document was filed in February.

* Price Action: CBLI shares are up 8.66% at $5.27 during the premarket trading session on the last check Friday.